STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?
In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
News archive
Health Tech
Topic file with published stories, monitored feeds, and source context.
27Stories
27Shown here
1Feeds
28Total signals
STAT+: A suspicious denial pattern in Medicare Advantage
Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.
STAT+: Abridge inks deals with Nvidia and Lilly
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
STAT+: AMA and lawmakers push back on AI care denials
In this edition of STAT Health Tech: HHS watchdog on denials by health insurers, lawmakers target AI denials, and Talkspace's new chatbot offering.
Dexcom RCT suggests CGM benefits for broad diabetes population
In this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.
STAT+: Utah Medical Board scolded for going rogue with AI criticism
In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.
STAT+: After hospitals, patients get a turn to bring AI into the doctor’s office
Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as diligent note-takers for patients.
Opinion: The medical-billing AI arms race between providers and insurance
“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.
Opinion: The virtual end of the doctor’s office waiting room
It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.
STAT+: Blood pressure tech floods the market after FDA relaxes wearables oversight
Wearables with unvalidated blood pressure measuring tech are flooding the market after the FDA relaxed oversight of wellness devices.
STAT+: Oura brings rings to the cuffless blood pressure party
In this edition of STAT Health Tech: A new wave of blood pressure monitoring wearables, Stanford asking patients about AI, and more.
STAT+: Where patients and hospitals disagree about AI
In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, and more health AI news.
Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot
Congressional Democrats are mounting a fresh effort to end a Medicare experiment to use AI to approve or deny care.
STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’
OpenEvidence CTO Zachary Ziegler said, at the STAT Breakthrough Summit West, that the company is looking beyond physician users.
STAT+: Dexcom CEO hints at future uses for CGM
In this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.
STAT+: Why big digital health players are missing from Medicare’s chronic care experiment
In this edition of STAT Health Tech: Why big digital health players skipped Medicare's ACCESS pilot, Isomorphic's big raise, and more.
STAT+: AI medical devices’ dirty FDA secret
In this edition of STAT's AI Prognosis newsletter: A look at the quirks of the most common FDA medical device approval pathway, sepsis algorithms, and more.
STAT+: Hims takes a $33 million hit from GLP-1 ‘pivot’
In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.
STAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victory
As new AI models for predicting sepsis hit the market, experts say performance alone will not drive adoption by hospitals.
Opinion: AI doctors should be licensed. Here’s a framework to do that
A state-by-state approach to clinical AI won’t work. Here’s a framework that can.
STAT+: Roche to buy PathAI for $750 million
Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.
Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting
“The pediatric and orphan pipeline is already the smallest, slowest, and least capitalized segment of the device industry,” writes Kolaleh Eskandanian.
STAT+: When the path to good AI is littered with bad data
In this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI models to be useful in health care.
STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’
Color Health, which coordinates cancer screening, is moving into a gap it observed — obtaining and coordinating actual cancer care.
STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and more
In this edition of STAT Health Tech: A health policy blueprint from OpenAI, CGM updates from Dexcom, and push back against whole body scans.
Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers
“Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record of science, a new study found